ID
40476
Beschrijving
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification; ODM derived from: https://clinicaltrials.gov/show/NCT02468661
Link
https://clinicaltrials.gov/show/NCT02468661
Trefwoorden
Versies (3)
- 17-01-19 17-01-19 -
- 20-04-20 20-04-20 -
- 25-04-20 25-04-20 -
Houder van rechten
Novartis Pharmaceuticals
Geüploaded op
25 april 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Non-Small Cell Lung Cancer NCT02468661
Eligibility Non-Small Cell Lung Cancer NCT02468661
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
EGFR-TKI Generation Third Prior treatment
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1443775
- UMLS CUI [1,2]
- C0079411
- UMLS CUI [1,3]
- C0205437
- UMLS CUI [1,4]
- C1514463
Beschrijving
Phase II of clinical trial only
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2974289
- UMLS CUI [1,2]
- C1514463
- UMLS CUI [2,1]
- C1999216
- UMLS CUI [2,2]
- C0072453
- UMLS CUI [2,3]
- C1514463
- UMLS CUI [3,1]
- C1999216
- UMLS CUI [3,2]
- C0062534
- UMLS CUI [3,3]
- C2985566
- UMLS CUI [3,4]
- C1514463
Beschrijving
Phase II of clinical trial only
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C1443775
- UMLS CUI [1,3]
- C1514463
- UMLS CUI [2,1]
- C1707479
- UMLS CUI [2,2]
- C1514162
- UMLS CUI [2,3]
- C0392920
- UMLS CUI [2,4]
- C1514463
- UMLS CUI [3]
- C1708063
Beschrijving
Phase II of clinical trial only
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C1708063
- UMLS CUI [1,3]
- C0392920
- UMLS CUI [1,4]
- C1514162
Similar models
Eligibility Non-Small Cell Lung Cancer NCT02468661
- StudyEvent: Eligibility
C0677984 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C3274204 (UMLS CUI [2])
C4289657 (UMLS CUI [3])
C0162789 (UMLS CUI [1,2])
C0072453 (UMLS CUI [2,1])
C1707513 (UMLS CUI [2,2])
C1443775 (UMLS CUI [1,2])
C0439661 (UMLS CUI [1,3])
C0079411 (UMLS CUI [1,4])
C0079411 (UMLS CUI [1,2])
C0205437 (UMLS CUI [1,3])
C1514463 (UMLS CUI [1,4])
C1514463 (UMLS CUI [1,2])
C1999216 (UMLS CUI [2,1])
C0072453 (UMLS CUI [2,2])
C1514463 (UMLS CUI [2,3])
C1999216 (UMLS CUI [3,1])
C0062534 (UMLS CUI [3,2])
C2985566 (UMLS CUI [3,3])
C1514463 (UMLS CUI [3,4])
C1443775 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C1707479 (UMLS CUI [2,1])
C1514162 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C1514463 (UMLS CUI [2,4])
C1708063 (UMLS CUI [3])
C1708063 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1514162 (UMLS CUI [1,4])